IDH1 and central nervous system cancer: Since lower grade, 1p/19q codeletion, MGMT promoter methylation, and IDH1 mutation were the major favorable prognostic markers for glioma, a subgroup analysis based on the status of these parameters was performed in both TCGA and CGGA cohort.